Show simple item record

dc.contributor.authorHanna, Kirollos S
dc.contributor.authorSegal, Eve M
dc.contributor.authorBarlow, Ashley
dc.contributor.authorBarlow, Brooke
dc.date.accessioned2021-01-13T19:45:59Z
dc.date.available2021-01-13T19:45:59Z
dc.date.issued2020-09-25
dc.identifier.urihttp://hdl.handle.net/10713/14355
dc.description.abstractThe national pandemic resulting from the novel coronavirus, COVID-19, has made the delivery of care for patients with cancer a challenge. There are competing risks of mortality from cancer versus serious complications and higher risk of death from COVID-19 in immunocompromised hosts. Furthermore, compounding these concerns is the inadequate supply of personal protective equipment, decreased hospital capacity, and paucity of effective treatments or vaccines to date for COVID-19. Guidance measures and recommendations have been published by national organizations aiming to facilitate the delivery of care in a safe and effective manner, many of which, are permanently adoptable interventions. Given the critical importance to continue chemotherapy, there remains additional interventions to further enhance patient safety while conserving healthcare resources such as adjustments in medication administration, reduction in laboratory or drug monitoring, and home delivery of specialty infusions. In this manuscript, we outline how to implement these actionable interventions of chemotherapy and supportive care delivery to further enhance the current precautionary measures while maintaining safe and effective patient care. Coupled with current published standards, these strategies can help alleviate the numerous challenges associated with this pandemic. © The Author(s) 2020.en_US
dc.description.urihttps://doi.org/10.1177/1078155220960211en_US
dc.language.isoenen_US
dc.publisherSAGE Publications Inc.en_US
dc.relation.ispartofJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitionersen_US
dc.subjectCOVID-19en_US
dc.subjectCanceren_US
dc.subjecthome infusionen_US
dc.subjectinfusion centeren_US
dc.subjectpandemicen_US
dc.titleClinical strategies for optimizing infusion center care through a pandemicen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1078155220960211
dc.identifier.pmid32972300
dc.source.volume27
dc.source.issue1
dc.source.beginpage165
dc.source.endpage179
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record